According to the expression patterns, prognostic significance and the biological processes of CTSB in gliomas, we deem that CTSB-based therapy might be an important strategy to improve the overall prognosis and the therapeutic reactivity of glioma patients. This evidence concerns the gene CTSB and central nervous system cancer.